News

Low-dose interleukin-2 added to standard ALS treatment extends patient survival, clinical trial finds
The results of the MIROCALS randomized clinical trial have shown that adding low-dose interleukin-2 (IL2LD) to standard ...
Type 5 diabetes is a newly recognized disease. Here are all the types of diabetes you need to know about
Type 5 diabetes has just been recognized as a distinct form of diabetes by the International Diabetes Federation. Despite the ...